Key Enzymes of Gluconeogenesis Are Dose-dependently Reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated Rats

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 1991 Jan 1

PMID 2059151

Citations 12

Authors

L W WEBER

M Lebofsky

H Greim

K Rozman

Affiliations

Soon will be listed here.

Abstract

Male Sprague-Dawley rats (240-245 g) were dosed ip with 5, 15, 25, or 125 micrograms/kg -,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in corn oil. Ad libitum-fed and pair-fed controls received vehicle (4 ml/kg) alone. Two or 8 days after dosing five rats of each group were sacrificed, their livers removed and assayed for the activities of three gluconeogenic enzymes [phosphoenol-pyruvate carboxykinase (PEPCK; EC 4.1.1.32), pyruvate carboxylase (PC; EC 6.4.1.1), and glucose-6-phosphatase (G-6-Pase, EC 3.13.9)], and one glycolytic enzyme [pyruvate kinase (PK; EC 2.7.1.40)] by established procedures. The activity of PK was not affected by TCDD at either time point. The activity of G-6-Pase tended to be decreased in TCDD-treated animals, as compared to pair-fed controls, but the decrease was variable without an apparent dose-response. The activity of PEPCK was significantly decreased 2 days after dosing, but a clear dose-response was apparent only at the 8-day time point. Maximum loss of activity at the highest dose was 56% below pair-fed control levels. PC activity was slightly decreased 2 days after TCDD treatment and displayed statistically significant, dose-dependent reduction by 8 days after dosing with a 49% loss of enzyme activity after the highest dose. It is concluded that inhibition of gluconeogenesis by TCDD previously demonstrated in vivo is probably due to decreased activities of PEPCK and PC. The data also support the prevailing view that PEPCK and PC are rate-determining enzymes in gluconeogenesis.

Citing Articles

Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD-dependent metabolic adaptation.

Bock K Arch Toxicol. 2021; 95(11):3449-3458.

PMID: 34559251 PMC: 8461142. DOI: 10.1007/s00204-021-03134-9.

Association of dioxin and other persistent organic pollutants (POPs) with diabetes: epidemiological evidence and new mechanisms of beta cell dysfunction.

De Tata V Int J Mol Sci. 2014; 15(5):7787-811.

PMID: 24802877 PMC: 4057704. DOI: 10.3390/ijms15057787.

Aryl hydrocarbon receptor activation by dioxin targets phosphoenolpyruvate carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP-ribose) polymerase (TiPARP).

Diani-Moore S, Zhang S, Ram P, Rifkind A J Biol Chem. 2013; 288(30):21514-25.

PMID: 23770670 PMC: 3724612. DOI: 10.1074/jbc.M113.458067.

Wildlife as sentinels of human health effects in the Great Lakes--St. Lawrence basin.

Fox G Environ Health Perspect. 2001; 109 Suppl 6:853-61.

PMID: 11744503 PMC: 1240620. DOI: 10.1289/ehp.01109s6853.

Relationships between environmental organochlorine contaminant residues, plasma corticosterone concentrations, and intermediary metabolic enzyme activities in Great Lakes herring gull embryos.

Lorenzen A, Moon T, Kennedy S, Glen G Environ Health Perspect. 1999; 107(3):179-86.

PMID: 10064546 PMC: 1566389. DOI: 10.1289/ehp.99107179.

References

Berndt J, Messner B, Turkki T, Weissmann E . Optical assay of pyruvate carboxylase in crude liver homogenates. Anal Biochem. 1978; 86(1):154-8. DOI: 10.1016/0003-2697(78)90329-9. View

HERS H, Hue L . Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem. 1983; 52:617-53. DOI: 10.1146/annurev.bi.52.070183.003153. View

Pilkis S, Fox E, Wolfe L, Rothbarth L, Colosia A, Stewart H . Hormonal modulation of key hepatic regulatory enzymes in the gluconeogenic/glycolytic pathway. Ann N Y Acad Sci. 1986; 478:1-19. DOI: 10.1111/j.1749-6632.1986.tb15517.x. View

Lucier G, McDaniel O, Hook G, Fowler B, Sonawane B, Faeder E . TCDD-induced changes in rat liver microsomal enzymes. Environ Health Perspect. 1973; 5:199-209. PMC: 1474969. DOI: 10.1289/ehp.7305199. View

Petrescu I, Bojan O, Saied M, Barzu O, Schmidt F, Kuhnle H . Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5'-diphosphate as nucleotide substrate. Anal Biochem. 1979; 96(2):279-81. DOI: 10.1016/0003-2697(79)90582-7. View

Zinkl J, Vos J, Moore J, Gupta B . Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ Health Perspect. 1973; 5:111-8. PMC: 1474973. DOI: 10.1289/ehp.7305111. View

GOODRIDGE A . Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism. Annu Rev Nutr. 1987; 7:157-85. DOI: 10.1146/annurev.nu.07.070187.001105. View

Pilkis S, El-Maghrabi M, Claus T . Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem. 1988; 57:755-83. DOI: 10.1146/annurev.bi.57.070188.003543. View

Butler P, Rizza R . Regulation of carbohydrate metabolism and response to hypoglycemia. Endocrinol Metab Clin North Am. 1989; 18(1):1-25. View

10.

Kitchin K, Woods J . 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) effects on hepatic microsomal cytochrome P-448-mediated enzyme activities. Toxicol Appl Pharmacol. 1979; 47(3):537-46. DOI: 10.1016/0041-008x(79)90524-6. View

11.

Imamura K, Tanaka T . Pyruvate kinase isozymes from rat. Methods Enzymol. 1982; 90 Pt E:150-65. DOI: 10.1016/s0076-6879(82)90121-5. View

12.

Gorski J, Muzi G, WEBER L, Pereira D, Arceo R, Iatropoulos M . Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Pathol. 1988; 16(3):313-20. DOI: 10.1177/019262338801600301. View

13.

Potter C, Sipes I, Russell D . Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration. Toxicol Appl Pharmacol. 1983; 69(1):89-95. DOI: 10.1016/0041-008x(83)90123-0. View

14.

Gorski J, WEBER L, Rozman K . Reduced gluconeogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Arch Toxicol. 1990; 64(1):66-71. DOI: 10.1007/BF01973379. View

15.

Gorski J, Rozman K . Dose-response and time course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Toxicology. 1987; 44(3):297-307. DOI: 10.1016/0300-483x(87)90031-x. View

16.

WEBER L, Lebofsky M, Stahl B, Gorski J, Muzi G, Rozman K . Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology. 1991; 66(2):133-44. DOI: 10.1016/0300-483x(91)90214-l. View

17.

WEBER L, Greim H, Rozman K . Metabolism and distribution of [14C]glucose in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Toxicol Environ Health. 1987; 22(2):195-206. DOI: 10.1080/15287398709531063. View

18.

GRANNER D, Andreone T . Insulin modulation of gene expression. Diabetes Metab Rev. 1985; 1(1-2):139-70. DOI: 10.1002/dmr.5610010108. View

19.

Wimhurst J, Manchester K . A comparison of the effects of diabetes induced with either alloxan or streptozotocin and of starvation on the activities in rat liver of the key enzymes of gluconeogenesis. Biochem J. 1970; 120(1):95-103. PMC: 1179572. DOI: 10.1042/bj1200095. View

20.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View